Based on previous findings that PPARγ is less expressed in lung tissue of patients with PAH [16] experimental data showed that insulin-sensitizing PPARγ agonists reduce PAH in rodent models [9, 31, 43, 48, 49]. The gene discussed is PPARG; the disease is pulmonary arterial hypertension.